Press

Press Releases

May 21, 2021

PharmaCCX announces Mel Walker joining as member of Advisory Board

May 10, 2021

Swedish HTA body (TLV) continues to support a market approach to assigning value to each drug in combination therapies

April 14, 2021

PharmaCCX announces Brian O'Rourke Joining as member of Advisory Board

April 12, 2021

Richard Bergström to depart PharmaCCX

August 1, 2020

PharmaCCX announces Carole Longson Joining as Special Counsel for Governance

April 14, 2020

Data Project to enable PharmaCCX negotiations is launched in Sweden

July 5, 2019

Swedish Government Agency TLV Asks PharmaCCX to Deploy Solution for Combination Pricing

November 20, 2018

PharmaCCX Raises Financing from Accel, Atlantic and Green D

In The News

March 08, 2021

STAT: Editorial by Nathan Sigworth
Why 2021 is the right time to scale managed entry agreements

February 01, 2021

STAT: Editorial by Nathan Sigworth
Four unexpected trends for health care investing in 2021

January 28, 2021

Vital Health Podcast:
PharmaCCX, a tech savvy solution for pricing EU cancer drugs

December 18, 2020

LIF (Swedish Pharma Association) responded to TLV report expressing a desire to work closely with payers on solving combo oncology challenges

December 8, 2020

TLV (Sweden) releases report on first negotiation on PharmaCCX Platform

December 4, 2020

Sweden's vaccine coordinator: It is now the seriousness begins

December 3, 2020

STAT: Editorial by Nathan Sigworth
Four reasons you should be optimistic about the future of drug pricing

Contingently Committed

A video series featuring industry experts and thought leaders at the intersection of technology, healthcare and pharma.

Alasdair Thong

Richard Bergstrom

Armen Solakhyan